2021 annual financial data

Atrium Therapeutics 2021 Operating margin

Direct answer

Operating margin was -1,265.83%.

Operating income was -118.05M USD and net income was -117.37M USD.
Operating cash flow was -94.81M USD.

Get free Atrium Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
9.33M USD
Operating income
-118.05M USD
Net income
-117.37M USD
Operating cash flow
-94.81M USD